FDP
ARQT icon

Financiere des Professionnels’s Arcutis Biotherapeutics ARQT Stock Holding History

Financiere des Professionnels’s Portfolio ARQT Stock Details ARQT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$328K Buy
12,491
+57
+0.5% +$1.33K 0.02% 278
2026
Q1 		$293K Hold
12,434
– – 0.02% 277
2025
Q4 		$361K Buy
+12,434
New +$318K 0.02% 242

Other funds holding ARQT

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Financiere des Professionnels's ARQT Position: Q2 2026 in Review

Financiere des Professionnels increased its Arcutis Biotherapeutics (ARQT) stake by 0.46% in Q2 2026, buying an estimated $1.33K and bringing the position to 12,491 shares worth $328K. The position accounts for 0.02% of the portfolio, ranked #278.

Financiere des Professionnels first reported a position in ARQT in Q4 2025 and has held it in 3 quarters since. The position peaked at $361K in Q4 2025. 273 funds tracked by Wall St. Rank hold ARQT as of Q2 2026.

  • Financiere des Professionnels held 12,491 shares of Arcutis Biotherapeutics worth $328K as of Q2 2026.
  • Financiere des Professionnels bought 57 Arcutis Biotherapeutics shares in Q2 2026, an estimated $1.33K.
  • Arcutis Biotherapeutics made up 0.02% of Financiere des Professionnels's portfolio in Q2 2026, its #278 holding.
  • Financiere des Professionnels first reported a position in Arcutis Biotherapeutics in Q4 2025 and has held it in 3 quarters since.
  • Financiere des Professionnels's Arcutis Biotherapeutics position peaked at $361K in Q4 2025.
  • 273 funds tracked by Wall St. Rank held Arcutis Biotherapeutics as of Q2 2026.

Based on Financiere des Professionnels's 13F filing for Q2 2026, filed 5 Aug 2026.